ClinVar Miner

Submissions for variant NM_000539.3(RHO):c.68C>T (p.Pro23Leu)

dbSNP: rs104893768
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001384458 SCV001583959 pathogenic not provided 2024-05-09 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 23 of the RHO protein (p.Pro23Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant inherited retinal dystrophy (PMID: 1833777; Invitae). ClinVar contains an entry for this variant (Variation ID: 1071889). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RHO protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RHO function (PMID: 8253795, 19913029, 24106275, 30977563). This variant disrupts the p.Pro23 amino acid residue in RHO. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 2137202, 28559085). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
GeneDx RCV001384458 SCV003840834 pathogenic not provided 2022-09-12 criteria provided, single submitter clinical testing Published functional studies demonstrate increased misfolding, decreased expression, and a damaging effect on transducin activation (Krebs et al., 2010; Opefi et al., 2013); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 1833777, 10668933, 35472194, 30977563, 19913029, 21094163, 8253795, 24106275, 27654411, 27149983)
Dept Of Ophthalmology, Nagoya University RCV003888084 SCV004705636 likely pathogenic Retinal dystrophy 2023-10-01 criteria provided, single submitter research
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV003888084 SCV005071938 pathogenic Retinal dystrophy 2008-01-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.